| scholarly article | Q13442814 |
| P50 | author | Nilgun Yildirim | Q57958156 |
| Nurşen Yüksel | Q90866387 | ||
| P2093 | author name string | Ufuk Elgin | |
| Nevbahar Tamçelik | |||
| Mehmet Okka | |||
| Ahmet Temel | |||
| Çiğdem Altan | |||
| Belgin Izgi | |||
| Altan Özcan | |||
| Baris Ozer | |||
| P2860 | cites work | Combination medical treatment for primary open angle glaucoma and ocular hypertension: a network meta-analysis | Q24192958 |
| Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial | Q30881058 | ||
| Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics | Q31857676 | ||
| Canadian Glaucoma Study: 2. risk factors for the progression of open-angle glaucoma | Q33359342 | ||
| An observational study of bimatoprost 0.01% in patients on prior intraocular pressure-lowering therapy: the Canadian Lumigan(®) RC Early Analysis Review (CLEAR) trial | Q33706842 | ||
| The frequency of exfoliation syndrome in the central anatolia region of Turkey. | Q34073270 | ||
| Long-term follow-up in preperimetric open-angle glaucoma: progression rates and associated factors. | Q50456294 | ||
| Diurnal and nocturnal variations in aqueous humor dynamics of patients with ocular hypertension undergoing medical therapy. | Q51423651 | ||
| The frequency of pseudoexfoliation syndrome in the middle Black Sea region of Turkey. | Q51767195 | ||
| Bimatoprost 0.01 % for previously treated patients with open-angle glaucoma or ocular hypertension in the Korean clinical setting. | Q52995234 | ||
| Intraocular pressure-lowering efficacy of dorzolamide/timolol fixed combination in normal-tension glaucoma. | Q53342706 | ||
| Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension | Q74150874 | ||
| A double-masked, randomized, parallel comparison of a fixed combination of bimatoprost 0.03%/timolol 0.5% with non-fixed combination use in patients with glaucoma or ocular hypertension | Q79760158 | ||
| High prevalence of anxiety and depression in patients with primary open-angle glaucoma | Q82295265 | ||
| Efficacy, tolerability and safety of the fixed combination of bimatoprost 0.03% and timolol 0.5% in a broad patient population: multicenter, open-label observational study | Q83484473 | ||
| A comparison of the safety and intraocular pressure lowering of bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in patients with open-angle glaucoma | Q94529097 | ||
| Safety and efficacy of bimatoprost/timolol fixed combination in Chinese patients with open-angle glaucoma or ocular hypertension | Q95559465 | ||
| Fixed combination of bimatoprost and timolol in patients with primary open-angle glaucoma or ocular hypertension with inadequate IOP adjustment | Q34188272 | ||
| Intraocular pressure-lowering effects of commonly used fixed-combination drugs with timolol: a systematic review and meta-analysis | Q34428023 | ||
| Bimatoprost/timolol versus travoprost/timolol fixed combinations in an Egyptian population: a hospital-based prospective randomized study. | Q34594495 | ||
| Natural history of open-angle glaucoma | Q35009399 | ||
| The pathophysiology and treatment of glaucoma: a review | Q35168230 | ||
| Intraocular pressure-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension | Q35762707 | ||
| Tolerability and efficacy of bimatoprost 0.01 % in patients with open-angle glaucoma or ocular hypertension evaluated in the Taiwanese clinical setting: the Asia Pacific Patterns from Early Access of Lumigan 0.01 % (APPEAL Taiwan) study | Q36134942 | ||
| Prevalence and predictors of depression among participants with glaucoma in a nationally representative population sample | Q36173937 | ||
| Twenty-four-hour effects of bimatoprost 0.01% monotherapy on intraocular pressure and ocular perfusion pressure | Q37634184 | ||
| Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects | Q37671448 | ||
| Anxiety and depression in Chinese patients with glaucoma: sociodemographic, clinical, and self-reported correlates | Q38113319 | ||
| Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. | Q38224185 | ||
| Prevalence of cognitive impairment, depression, and anxiety symptoms among older adults with glaucoma | Q39780790 | ||
| A comparative study on the efficacy, safety, and cost-effectiveness of bimatoprost/timolol and dorzolamide/timolol combinations in glaucoma patients | Q41523626 | ||
| The frequency of pseudoexfoliation syndrome in the Eastern Mediterranean area of Turkey | Q42022898 | ||
| An evaluation of the rate of nonresponders to latanoprost therapy | Q42688560 | ||
| Hyperemia reduction after administration of a fixed combination of bimatoprost and timolol maleate to patients on prostaglandin or prostamide monotherapy. | Q42844875 | ||
| Comparison of Travoprost and Bimatoprost plus timolol fixed combinations in open-angle glaucoma patients previously treated with latanoprost plus timolol fixed combination | Q42945175 | ||
| IOP-lowering efficacy and tolerability of preservative-free tafluprost 0.0015% among patients with ocular hypertension or glaucoma | Q43018878 | ||
| Twelve-month, randomized, controlled trial of bimatoprost 0.01%, 0.0125%, and 0.03% in patients with glaucoma or ocular hypertension | Q43116993 | ||
| The safety and efficacy of bimatoprost/timolol fixed combination: a 1-year double-masked, randomized parallel comparison to its individual components in patients with glaucoma or ocular hypertension | Q43255314 | ||
| Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: a 30-day comparison with latanoprost | Q43660041 | ||
| Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension | Q43747342 | ||
| A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma | Q44264227 | ||
| Timolol 0.5%/dorzolamide 2% fixed combination vs timolol maleate 0.5% and unoprostone 0.15% given twice daily to patients with primary open-angle glaucoma or ocular hypertension | Q44301726 | ||
| Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure | Q44414154 | ||
| A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study | Q44420267 | ||
| 24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial | Q44796835 | ||
| Anxiety, depression, and quality of life in Turkish patients with glaucoma | Q45288386 | ||
| Incidence of hyperemia associated with bimatoprost treatment in naïve subjects and in subjects previously treated with latanoprost. | Q46035552 | ||
| Efficacy of the fixed combinations of bimatoprost or latanoprost plus timolol in patients uncontrolled with prostaglandin monotherapy: a multicenter, randomized, investigator-masked, clinical study | Q46175319 | ||
| Bimatoprost/timolol fixed combination vs latanoprost/timolol fixed combination in open-angle glaucoma patients | Q46554989 | ||
| Bimatoprost/timolol fixed combination: a 3-month double-masked, randomized parallel comparison to its individual components in patients with glaucoma or ocular hypertension | Q46643384 | ||
| A comparison of travoprost, latanoprost, and the fixed combination of dorzolamide and timolol in patients with pseudoexfoliation glaucoma | Q46958995 | ||
| Depression, anxiety, and disturbed sleep in glaucoma | Q47980307 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | open-angle glaucoma | Q3108586 |
| multicenter clinical trial | Q6934595 | ||
| P304 | page(s) | 723-731 | |
| P577 | publication date | 2017-04-19 | |
| P1433 | published in | Clinical Ophthalmology | Q5133782 |
| P1476 | title | Prospective, non-interventional, multicenter study of the intraocular pressure-lowering effects of prostaglandin analog/prostamide-containing therapies in previously treated patients with open-angle glaucoma or ocular hypertension | |
| P478 | volume | 11 |
Search more.